Skip to content

Combined Spinal/Epidural (CSE) Saline Duration/Spread

Effect of Epidural Saline on Duration and Spread of Subsequent Spinal Analgesia/Anesthesia Using a CSE Technique

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01062893
Enrollment
82
Registered
2010-02-04
Start date
2009-08-31
Completion date
2012-09-30
Last updated
2018-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Keywords

labor pain treatment, duration analgesia, Analgesic duration with normal saline injection., Analgesic duration without normal saline injection

Brief summary

An attempt is being made to see if by injecting a set volume of sterile saline into the epidural space during the treatment of labor pain with a combined spinal/epidural (CSE) increases the amount of pain relief obtained and makes the labor analgesia lasts longer. Subjects are in the study from the time their CSE is placed until they request additional pain medication from the spinal dose of numbing medicine wearing off.

Interventions

OTHERSterile normal saline 0 mls

at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.

OTHER15 mls sterile normal saline

After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age greater than 12 years of age * ASA status 1 or 2 * cervical dilation \< 6cm

Exclusion criteria

* ASA assigned 3 or 4 * advanced labor (\> 6cm cervical dilated) * distorted epidural anatomy

Design outcomes

Primary

MeasureTime frameDescription
Highest Sensory Blockade Level to Pinprick and to Coldup to 20 minutesOnset of analgesia to recession of analgesia. Highest spread of analgesia (highest sensory level) to cold temp and pinprick, with level defined from T1 to L5, where T1 is highest =level 17 and L5 is lowest =Level 1)

Secondary

MeasureTime frameDescription
Onset of Analgesiaup to 20 minutestime to VAS\</=3 on a 0-10 scale with 0=no pain up to 10= worst pain imaginable
Time to Highest Sensory Blockup to 20 minutes
Number of Participants Who Had Occurrence of Fetal Bradycardialength of labor, up to 24 hoursoccurrence of common side effects of spinal/epidural administration
Number of Participants Who Had Occurrence of Maternal Hypotensionlength of labor, up to 24 hours
Duration of Analgesia (Time to Request Additional Analgesia)up 120 minutestime of CSE to time request of additional supplement analgesia in minutes
Number of Participants Who Had Occurrence of Itchinglength of labor, up to 24 hours
Number of Participants Who Had Occurrence of Post Dural Puncture Headachelength of labor, up to 24 hours
Time for 2 Dermatome Level Regression of Sensory Blockup to 20 minutes
Time for Regression of Motor Blockadeup to 20 minutes
Occurrence of Use of Vasopressorslength of labor, up to 24 hours

Countries

United States

Participant flow

Participants by arm

ArmCount
0 Mls Saline Injected
NO SALINE INJECTED Sterile normal saline 0 mls: at time of epidural needle placement there will not be any saline injected into the epidural space prior to placement of the spinal needle to administer the CSE dose of standard analgesic medications. Instead a pause will be done as by the investigator to maintain blind for the assessor.
27
15 Mls Saline
15ML SALINE ADMINISTERED EPIDURALLY 15 mls sterile normal saline: After the epidural needle is placed, 15 mls of sterile normal saline will be injected into the epidural space, then the spinal needle will be placed to administer the CSE dose of standard analgesic medications.
28
Total55

Baseline characteristics

Characteristic0 Mls Saline Injected15 Mls SalineTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
27 Participants28 Participants55 Participants
Region of Enrollment
United States
27 participants28 participants55 participants
Sex: Female, Male
Female
27 Participants28 Participants55 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 270 / 28
other
Total, other adverse events
0 / 270 / 28
serious
Total, serious adverse events
0 / 270 / 28

Outcome results

Primary

Highest Sensory Blockade Level to Pinprick and to Cold

Onset of analgesia to recession of analgesia. Highest spread of analgesia (highest sensory level) to cold temp and pinprick, with level defined from T1 to L5, where T1 is highest =level 17 and L5 is lowest =Level 1)

Time frame: up to 20 minutes

ArmMeasureValue (MEAN)Dispersion
0 Mls Saline InjectedHighest Sensory Blockade Level to Pinprick and to Cold10.1 units on a scaleStandard Deviation 2.9
15 Mls SalineHighest Sensory Blockade Level to Pinprick and to Cold11.6 units on a scaleStandard Deviation 1.9
Secondary

Duration of Analgesia (Time to Request Additional Analgesia)

time of CSE to time request of additional supplement analgesia in minutes

Time frame: up 120 minutes

ArmMeasureValue (MEAN)Dispersion
0 Mls Saline InjectedDuration of Analgesia (Time to Request Additional Analgesia)57.2 minutesStandard Deviation 33.9
15 Mls SalineDuration of Analgesia (Time to Request Additional Analgesia)77.3 minutesStandard Deviation 30
Secondary

Number of Participants Who Had Occurrence of Fetal Bradycardia

occurrence of common side effects of spinal/epidural administration

Time frame: length of labor, up to 24 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
0 Mls Saline InjectedNumber of Participants Who Had Occurrence of Fetal Bradycardia1 Participants
15 Mls SalineNumber of Participants Who Had Occurrence of Fetal Bradycardia0 Participants
Secondary

Number of Participants Who Had Occurrence of Itching

Time frame: length of labor, up to 24 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
0 Mls Saline InjectedNumber of Participants Who Had Occurrence of Itching1 Participants
15 Mls SalineNumber of Participants Who Had Occurrence of Itching1 Participants
Secondary

Number of Participants Who Had Occurrence of Maternal Hypotension

Time frame: length of labor, up to 24 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
0 Mls Saline InjectedNumber of Participants Who Had Occurrence of Maternal Hypotension2 Participants
15 Mls SalineNumber of Participants Who Had Occurrence of Maternal Hypotension4 Participants
Secondary

Number of Participants Who Had Occurrence of Post Dural Puncture Headache

Time frame: length of labor, up to 24 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
0 Mls Saline InjectedNumber of Participants Who Had Occurrence of Post Dural Puncture Headache0 Participants
15 Mls SalineNumber of Participants Who Had Occurrence of Post Dural Puncture Headache0 Participants
Secondary

Occurrence of Use of Vasopressors

Time frame: length of labor, up to 24 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
0 Mls Saline InjectedOccurrence of Use of Vasopressors10 Participants
15 Mls SalineOccurrence of Use of Vasopressors12 Participants
Secondary

Onset of Analgesia

time to VAS\</=3 on a 0-10 scale with 0=no pain up to 10= worst pain imaginable

Time frame: up to 20 minutes

ArmMeasureValue (MEAN)Dispersion
0 Mls Saline InjectedOnset of Analgesia7.96 minutesStandard Deviation 5.24
15 Mls SalineOnset of Analgesia6.07 minutesStandard Deviation 3.15
Secondary

Time for 2 Dermatome Level Regression of Sensory Block

Time frame: up to 20 minutes

Population: No data collected

Secondary

Time for Regression of Motor Blockade

Time frame: up to 20 minutes

Population: No data collected

Secondary

Time to Highest Sensory Block

Time frame: up to 20 minutes

ArmMeasureValue (MEAN)Dispersion
0 Mls Saline InjectedTime to Highest Sensory Block12.96 minutesStandard Deviation 8.69
15 Mls SalineTime to Highest Sensory Block13.57 minutesStandard Deviation 6.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026